Back to Results
First PageMeta Content
Orphan drugs / Organofluorides / Pyridines / Organochlorides / Piperazines / Sunitinib / Renal cell carcinoma / Chronic myelogenous leukemia / Sorafenib / Medicine / Chemistry / Oncology


SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Filgrastim, Capecitabine, Imatinib, Dasatinib, Erolotinib, Sunitinib, Pazopanib, Fludarabine, Sorafenib, Crizotinib, Tretinoin, Nilotinib, Temozolomid
Add to Reading List

Document Date: 2015-04-28 07:44:05


Open Document

File Size: 123,39 KB

Share Result on Facebook
UPDATE